Top Markets
Coin of the day
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Rang în acțiuni #6151
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Preț acțiune
$153.93
Capitalizare de piață
$2.21B
Schimbare (1 zi)
-0.26%
Schimbare (1 an)
172.68%
Țară
US
Tranzacționează Palvella Therapeutics, Inc. (PVLA)

Categorie

Istoricul spliturilor pentru Palvella Therapeutics, Inc. (PVLA)
Acțiunea Palvella Therapeutics, Inc. (simbol: PVLA) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 27, 2026.
O acțiune PVLA cumpărată înainte de Aug 27, 2026 este echivalentă astăzi cu 0 acțiuni PVLA.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH